Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients

Leuk Lymphoma. 2022 Dec;63(13):3237-3240. doi: 10.1080/10428194.2022.2116931. Epub 2022 Sep 1.

Anna Durinikova^{1

2}, Adam Folta¹, Filip Pardy³, Jan Svaton^{1

3}, Marie Drncova^{1

2}, Barbora Weinbergerova^{1

2}, Petr Cetkovsky⁴, Zdenek Racil⁴, Pavel Jindra⁵, Tomas Szotkowski⁶, Pavel Zak⁷, Jiri Mayer^{1

2

3}, Ivana Jeziskova^{1

2}

¹ Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
² Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
³ Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
⁴ Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
⁵ Department of Hematology and Oncology, University Hospital Pilsen, Pilsen, Czech Republic.
⁶ Department of Hemato-Oncology, University Hospital Olomouc, Olomouc, Czech Republic.
⁷ Department of Internal Medicine - Department of Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.

No abstract available

Publication types